Q2 2025 Holdings
Filed 2025-08-14 | 12 holdings | $369.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $192.5M | 10,632,113 | 52.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $52.0M | 5,462,846 | 14.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $36.3M | 3,909,696 | 9.8% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $35.1M | 9,632,561 | 9.5% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $24.0M | 3,452,330 | 6.5% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $23.4M | 4,107,537 | 6.3% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $3.5M | 440,176 | 0.9% |
| Engene Holdings Inc(ENGNW) | W EXP 10/31/2028 | 29286M113 | $2.4M | 2,878,148 | 0.6% |